The Medicines Company (MDCO +0.6%) says its global license and two-year collaboration with...

|About: The Medicines Company (MDCO)|By:, SA News Editor

The Medicines Company (MDCO +0.6%) says its global license and two-year collaboration with Bristol-Myers (BMY +1.2%) for Recothrom, a recombinant thrombin approved by the FDA as a topical hemostat to control non-arterial bleeding during surgical procedures, has become effective.